{"id":3196,"date":"2017-10-20T09:17:57","date_gmt":"2017-10-20T13:17:57","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=3196"},"modified":"2017-10-20T10:44:09","modified_gmt":"2017-10-20T14:44:09","slug":"new-filings-updated-terms-week-ending-10-20-17","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/new-filings-updated-terms-week-ending-10-20-17\/","title":{"rendered":"New Filings &#038; Updated Terms (Week Ending 10.20.17)"},"content":{"rendered":"<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/09\/Screen-Shot-2017-09-22-at-9.34.24-AM.png\"><br \/>\n<\/a>IPO Boutique keeps apprised of the active pipeline. Currently there are 78 active IPOs in the pipeline as of October 20, 2017. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0<a href=\"http:\/\/www.ipoboutique.com\/blog\/?p=2877\" target=\"_blank\"><strong>in this article.<\/strong><\/a><\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/10\/Screen-Shot-2017-10-20-at-8.51.39-AM.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter size-full wp-image-3198\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/10\/Screen-Shot-2017-10-20-at-8.51.39-AM.png\" alt=\"Screen Shot 2017-10-20 at 8.51.39 AM\" width=\"654\" height=\"405\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/10\/Screen-Shot-2017-10-20-at-8.51.39-AM.png 654w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/10\/Screen-Shot-2017-10-20-at-8.51.39-AM-600x372.png 600w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2017\/10\/Screen-Shot-2017-10-20-at-8.51.39-AM-300x186.png 300w\" sizes=\"(max-width: 654px) 100vw, 654px\" \/><\/a><\/p>\n<p><strong>NEW FILINGS<\/strong><\/p>\n<p>Company: Apellis Pharmaceuticals<br \/>\nSymbol: APLS<br \/>\nDescription: They are a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutic compounds for autoimmune and inflammatory diseases.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Citigroup, J.P. Morgan<br \/>\nFiled 10-13-17<br \/>\nListed Cash Raise: $150 million<br \/>\nNote: Previously withdrawn in February 2016<\/p>\n<p>Company: CBTX, Inc<br \/>\nSymbol: CBTX<br \/>\nDescription: They are a bank holding company that operates through our wholly-owned subsidiary, CommunityBank of Texas, in Houston and Beaumont, Texas.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Stephens, Keefe Bruyette &amp; Woods, Sandler O&#8217; Neill + Partners<br \/>\nFiled 10-13-17<br \/>\nListed Cash Raise: $50 million<\/p>\n<p>Company: Bandwidth, Inc<br \/>\nSymbol: BAND<br \/>\nDescription: They are a leading cloud-based communications platform for enterprises in the United States.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Morgan Stanley, Keybanc Capital, Baird<br \/>\nCo-Manager(s): Canaccord Genuity, JMP Securities<br \/>\nFiled 10-13-17<br \/>\nListed Cash Raise: $85 million<\/p>\n<p>Company: Four Seasons Education (Cayman) Inc.<br \/>\nSymbol: TBD<br \/>\nDescription: They are dedicataed to providing high quality math education. In 2016 and the six months ended June 30, 2017, we were the largest after-school math education service provider for elementary school students in Shanghai, as measured by gross billings and number of students, according to the Frost &amp; Sullivan Report.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Morgan Stanley, Citigroup, China Renaissance<br \/>\nFiled 10-13-17<br \/>\nListed Cash Raise: $120 million<\/p>\n<p>Company: PPDAI Group Inc.<br \/>\nSymbol: PPDF<br \/>\nDescription: They are a leading online consumer finance marketplace in China with strong brand recognition.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Credit Suisse, Citigroup<br \/>\nCo-Manager(s): Keefe Bruyette &amp; Woods<br \/>\nFiled 10-13-17<br \/>\nListed Cash Raise: $350 million<\/p>\n<p>Company: Fireman B.V.<br \/>\nSymbol: IFRX<br \/>\nDescription: They are a clinical stage biopharmaceutical company focused on applying their proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): J.P. Morgan, Leerink Partners, BMO Capital Markets<br \/>\nFiled 10-13-17<br \/>\nListed Cash Raise: $86.25 million<\/p>\n<p>Company: Workspace Property Trust<br \/>\nSymbol: WSPT<br \/>\nDescription: Workspace Property Trust is a fully integrated real estate investment company primarily focused on acquiring, owning and operating high-quality office and flex real estate in prime locations within transit centric, amenity rich U.S. suburban office submarkets.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Goldman Sachs &amp; Co, J.P. Morgan, BofA Merrill Lynch<br \/>\nFiled 10-16-17<br \/>\nListed Cash Raise: $100 million<\/p>\n<p>Company: SendGrid, Inc.<br \/>\nSymbol: SEND<br \/>\nDescription: They are a leading digital communication platform, enabling businesses to engage with their customers via email reliably, effectively and at scale.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Morgan Stanley, J.P. Morgan<br \/>\nCo-Manager(s): William Blair, KeyBanc Capital Markets, Piper Jaffray, Stifel<br \/>\nFiled 10-18-17<br \/>\nListed Cash Raise: $100 million<\/p>\n<p>Company: Stitch Fix, Inc.<br \/>\nSymbol: SFIX<br \/>\nDescription: They are reinventing the shopping experience by delivering one-to-one personalization to our clients through the combination of data science and human judgment.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Goldman Sachs &amp; Co., J.P. Morgan<br \/>\nCo-Manager(s): Barclays, RBC Capital Markets, Piper Jaffray, Stifel, William Blair<br \/>\nFiled 10-19-17<br \/>\nListed Cash Raise: $100 million<\/p>\n<p>Company: Sterling Bancorp, Inc.<br \/>\nSymbol: TBD<br \/>\nDescription: They are a unitary thrift holding company headquartered in Southfield, Michigan with our primary branch operations in San Francisco and Los Angeles, California.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Sandler O\u2019 Neill + Partners<br \/>\nFiled 10-19-17<br \/>\nListed Cash Raise: $230 million<\/p>\n<p>Company: WatchGuard, Inc.<br \/>\nSymbol: WGRD<br \/>\nDescription: They are the leading provider of mobile video solutions for law enforcement. Our products include in-car video systems, body-worn cameras and evidence management software.<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Barclays, SunTrust Robinson Humphrey<br \/>\nCo-Manager(s): Oppenheimer &amp; Co., Cowen<br \/>\nFiled 10-19-17<br \/>\nListed Cash Raise: $75 million<\/p>\n<p>TERMS ADDED<\/p>\n<p>Company: Merchants Bancorp<br \/>\nSymbol: MBIN<br \/>\nDescription: They are a diversified bank holding company headquartered in Carmel, Indiana and registered under the Bank Holding Company Act of 1956, as amended.<br \/>\nShares: 5.55 million<br \/>\nPrice Range: $17.00-$19.00<br \/>\nTrade Date: 10\/27<br \/>\nUnderwriter(s): Sandler O&#8217;Neill + Partners, Stephens Inc., Raymond James<br \/>\nCo-Manager: SunTrust Robinson<br \/>\nFiled 10-16-17<\/p>\n<p>Company: National Vision Holdings, Inc.<br \/>\nSymbol: EYE<br \/>\nDescription: They are one of the largest and fastest growing optical retailers in the United States and a leader in the attractive value segment of the U.S. optical retail industry.<br \/>\nShares: 15.8 million<br \/>\nPrice Range: $18.00-$20.00<br \/>\nTrade Date: 10\/26<br \/>\nUnderwriter(s): BofA Merrill Lynch, Goldman Sachs &amp; Co., Citigroup, KKR, Morgan Stanley, Jefferies, UBS Investment Bank, Wells Fargo Securities<br \/>\nCo-Manager(s): Guggenheim Securities, Mizuho Securities, Macquarie Capital<br \/>\nFiled 10-16-17<\/p>\n<p>Company: BP Midstream Partners LP<br \/>\nSymbol: BPMP<br \/>\nDescription: They are a fee-based, growth-oriented master limited partnership recently formed by BP Pipelines, an indirect wholly owned subsidiary of BP, to own, operate, develop and acquire pipelines and other midstream assets.<br \/>\nShares: 42.5 million<br \/>\nPrice Range: $19.00-$21.00<br \/>\nTrade Date: 10\/26<br \/>\nUnderwriter(s): Citigroup, Goldman Sachs &amp; Co., Morgan Stanley, Barclays, Credit Suisse, J.P. Morgan, UBS Investment Bank<br \/>\nCo-Manager(s): BofA Merrill Lynch, Deutsche Bank Securities, Mizuho Securities, MUFG, BNP PARIBAS, Credit Agricole CIB, SOCIETE GENERALE<br \/>\nFiled 10-16-17<\/p>\n<p>Company: Forescout Technologies, Inc.<br \/>\nSymbol: FSCT<br \/>\nDescription: They have pioneered an agentless approach to network security to protect organizations against the emerging threats that exploit the billions of devices connected to organizations\u2019 networks.<br \/>\nShares: 4.8 million<br \/>\nRange: $20.00-$22.00<br \/>\nTrade Date: 10\/27<br \/>\nUnderwriter(s): Morgan Stanley, J.P. Morgan, Citigroup<br \/>\nCo-Manager(s): BofA Merrill Lynch, UBS Investment Bank, KeyBanc Capital Markets<br \/>\nTerms Added: 10-16-17<\/p>\n<p>Company: Hexindai, Inc<br \/>\nSymbol: HX<br \/>\nDescription: They are a fast-growing consumer lending marketplace facilitating loans to meet the increasing consumption demand of the emerging middle class in China.<br \/>\nShares: 2.7 &#8211; 8.9 million<br \/>\nPrice Range: $9.00-$11.00<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Network 1 Securities<br \/>\nTerms Added: 10-16-17<\/p>\n<p>Company: Evoqua Water Technologies Corp.<br \/>\nSymbol: AQUA<br \/>\nDescription: They are a leading provider of mission critical water treatment solutions, offering services, systems and technologies to support our customers&#8217; full water lifecycle needs.<br \/>\nShares: 27.8 million<br \/>\nRange: $17.00-$19.00<br \/>\nTrade Date: 11\/2<br \/>\nUnderwriter(s): Credit Suisse, J.P Morgan, RBC Capital, Citigroup, Goldman Sachs &amp; Co.<br \/>\nCo-Manager(s): Morgan Stanley, Baird, Raymond James, Stifel, Wells Fargo Securities<br \/>\nTerms Added: 10-18-17<\/p>\n<p>Company: ACM Research, Inc.<br \/>\nSymbol: ACMR<br \/>\nDescription: They develop, manufacture and sell single-wafer wet cleaning equipment, which semiconductor manufacturers can use in numerous manufacturing steps to remove particles, contaminants and other random defects, and thereby improve product yield, in fabricating advanced integrated circuits, or chips.<br \/>\nShares: 2 million<br \/>\nPrice Range: $7.50-$9.50<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Roth Capital Partners<br \/>\nCo-Manager(s): Craig Hallum Capital, The Benchmark Company<br \/>\nTerms Added: 10-18-17<\/p>\n<p>Company: Altair Engineering, Inc<br \/>\nSymbol: ALTR<br \/>\nDescription: They are a leading provider of enterprise-class engineering software enabling innovation across the entire product lifecycle from concept design to in-service operation.<br \/>\nShares: 12 million<br \/>\nPrice Range: $11.00-$13.00<br \/>\nTrade Date: 11\/1<br \/>\nUnderwriter(s): J.P. Morgan, RBC Capital Markets, Deutsche Bank Securities<br \/>\nCo-Manager(s): William Blair, Canaccord Genuity<br \/>\nTerms Added: 10-19-17<\/p>\n<p>Company: Prolung, Inc.<br \/>\nSymbol: LUNG<br \/>\nDescription: They are a medical technology company specializing in predictive analytic, early stage lung cancer risk testing, which we refer to as the \u201cProLung Test.\u201d<br \/>\nShares: 0.93 million<br \/>\nPrice Range: $7.00-$8.00<br \/>\nTrade Date: TBD<br \/>\nUnderwriter(s): Maxim Group, Aegis<br \/>\nTerms Added: 10-17-17<\/p>\n<p>Company: Ablynx NV<br \/>\nSymbol: ABLX<br \/>\nDescription: They are a late-stage clinical biopharmaceutical company utilizing our proprietary Nanobody platform to develop treatments for a broad range of therapeutic indications with an unmet medical need. Their ordinary shares are listed on Euronext Brussels under the symbol &#8216;ABLX&#8217;.<br \/>\nShares: 7.16 million<br \/>\nPrice Range: $20.95-$20.95<br \/>\nTrade Date: 10\/25<br \/>\nUnderwriter(s): BofA Merrill Lynch, J.P. Morgan, Jefferies<br \/>\nCo-Manager(s): Baird, Bryan Garnier &amp; Co., Ladenburg Thalmann<br \/>\nTerms Added: 10-17-17<\/p>\n","protected":false},"excerpt":{"rendered":"<p>IPO Boutique keeps apprised of the active pipeline. Currently there are 78 active IPOs in the pipeline as of October 20, 2017. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article. NEW FILINGS Company: Apellis[&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[1],"tags":[],"class_list":["post-3196","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3196","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=3196"}],"version-history":[{"count":3,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3196\/revisions"}],"predecessor-version":[{"id":3200,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3196\/revisions\/3200"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=3196"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=3196"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=3196"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}